In an interview with Targeted Oncology, Pavlos Msaouel, MD, PhD, at The University of Texas MD Anderson Cancer Center ...

A kidney cancer survivor shares how a decade of breakthroughs in immunotherapy and targeted research transformed a death ...

Vegetarians showed lower risks for pancreatic, breast, prostate, kidney cancers, and multiple myeloma compared to meat eaters ...

For most patients diagnosed with kidney cancer, the standard playbook is clear. Immunotherapy and targeted therapies directed ...

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.

Advanced Urology founder Dr. Jitesh Patel brings histotripsy to Atlanta — a non-invasive, scalpel-free breakthrough for ...

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

New global research reveals complex links between diet types and cancer risks, including surprising findings for vegetarians ...

Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and ...

Patients with a history of breast, kidney, lung and several other types of cancer who undergo solid organ transplant have a significantly higher risk for developing a second malignancy at the same ...

Data build on findings presented at ESMO 2025 and support potential of darlifarnib to overcome resistance and resensitize ...

Patients with advanced kidney cancer, or renal cell carcinoma, have several new treatment paths to consider following the ...